UK Renal Registry 18th Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2014: National and Centre-specific Analyses

被引:2
作者
Pruthi, Rishi [1 ]
Casula, Anna [2 ]
MacPhee, Iain [3 ]
机构
[1] Guys & St Thomas NHS Trust, London, England
[2] UK Renal Registry, Bristol, Avon, England
[3] St Georges Univ London, London, England
关键词
Blood pressure; Bone metabolism; Chronic kidney disease; Clinical Commissioning Group; Deceased donor; eGFR; Epidemiology; Ethnicity; Graft function; Haemoglobin; Live donor; Outcomes; Renal transplantation; Survival; DISEASE;
D O I
10.1159/000444817
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 ; 100201 ;
摘要
There was a 2% fall in overall renal transplant numbers in 2014, with a significant fall in kidney donation from donors after circulatory death (10%). In 2014, death-censored renal transplant failure rates in prevalent patients were similar to previous years at 2.4% per annum. Transplant patient death rates remained stable at 2.3 per 100 patient years. The median age of incident and prevalent renal transplant patients in the UK was 50.6 and 53.3 years respectively. The median eGFR of prevalent renal transplant recipients was 52.5 ml/min/1.73 m(2).. The median eGFR of patients one year after transplantation was 57.4 ml/min/1.73 m(2) post live transplant, 53.6 ml/min/1.73 m(2) post brainstem death transplant and 50.1 ml/min/1.73 m(2) post circulatory death transplant. In 2014, 13% of prevalent transplant patients had eGFR,30 ml/min/1.73 m(2). . The median decline in eGFR slope beyond the first year after transplantation was -0.48 ml/min/1.73 m(2)/year. In 2014, malignancy (26%) and infection (24%) remained the commonest causes of death in patients with a functioning renal transplant.
引用
收藏
页码:69 / 98
页数:30
相关论文
共 14 条
  • [1] Ansell David, 2009, Nephron Clin Pract, V111 Suppl 1, pc277, DOI 10.1159/000210004
  • [2] Predictive performance of renal function equations in renal transplant recipients: An analysis of patient factors in bias
    Bosma, RJ
    Doorenbos, CRC
    Stegeman, CA
    van der Heide, JJH
    Navis, G
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2005, 5 (09) : 2193 - 2203
  • [3] Predictive performance of the Modification of Diet in Renal Disease and Cockcroft-Gault equations for estimating renal function
    Froissart, M
    Rossert, J
    Jacquot, C
    Paillard, M
    Houillier, P
    [J]. JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY, 2005, 16 (03): : 763 - 773
  • [4] Post-transplant renal function in the first year predicts long-term kidney transplant survival
    Hariharan, S
    McBride, MA
    Cherikh, WS
    Tolleris, CB
    Bresnahan, BA
    Johnson, CP
    [J]. KIDNEY INTERNATIONAL, 2002, 62 (01) : 311 - 318
  • [5] Racial disparities in renal transplant outcomes
    Isaacs, RB
    Nock, SL
    Spencer, CE
    Conners, AF
    Wang, XQ
    Sawyer, R
    Lobo, PI
    [J]. AMERICAN JOURNAL OF KIDNEY DISEASES, 1999, 34 (04) : 706 - 712
  • [6] Black renal transplant recipients have poorer long-term graft survival than CYP3A5 expressers from other ethnic groups
    Ng, Fu Liang
    Holt, David W.
    Chang, Rene W. S.
    MacPhee, Iain A. M.
    [J]. NEPHROLOGY DIALYSIS TRANSPLANTATION, 2010, 25 (02) : 628 - 634
  • [7] UK Renal Registry 17th Annual Report: Chapter 11 Centre Variation in Access to Renal Transplantation in the UK (2008-2010)
    Pruthi, Rishi
    Curnow, Elinor
    Roderick, Paul
    Ravanan, Rommel
    [J]. NEPHRON, 2015, 129 : 247 - 256
  • [8] UK Renal Registry 17th Annual Report: Chapter 3 Demographic and Biochemistry Profile of Kidney Transplant Recipients in the UK in 2013: National and Centre-specific Analyses
    Pruthi, Rishi
    Casula, Anna
    MacPhee, Iain
    [J]. NEPHRON, 2015, 129 : 57 - 86
  • [9] Chronic Kidney Disease in Kidney Transplant Recipients-Is It Different From Chronic Native Kidney Disease?
    Udayaraj, Udaya P.
    Casula, Anna
    Ansell, David
    Dudley, Christopher R. K.
    Ravanan, Rommel
    [J]. TRANSPLANTATION, 2010, 90 (07) : 765 - 770
  • [10] UK Renal Association Clinical Practice Guidelines Committee, 2007, GUID 3 7 TARG HAEM 2